Coherus Oncology, Inc. (CHRS)

CIK 1512762 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Coherus Oncology, Inc..

Recent SEC filings

FiledFormAccession number
Aug 28, 20268-K0001104659-26-103316
Aug 28, 2026424B50001104659-26-103241
Aug 28, 2026424B30001104659-26-103239
Aug 17, 20268-K0001104659-26-097951
Aug 17, 20268-K0001104659-26-097949
Aug 5, 20268-K0001104659-26-091188
Aug 5, 2026S-80001104659-26-091276
Aug 5, 202610-Q0001104659-26-091262
Jul 27, 2026SCHEDULE 13G0002012383-26-002236
Jun 15, 20268-K0001104659-26-074090
Jun 9, 202640001610717-26-000202
Jun 9, 202640001610717-26-000206
Jun 9, 202640001610717-26-000203
Jun 9, 202640001610717-26-000204
Jun 9, 202640001610717-26-000201
Jun 9, 202640001610717-26-000200
Jun 9, 202640001610717-26-000205
Jun 2, 202640001104659-26-069621
Jun 2, 202640001104659-26-069622
Jun 1, 20268-K0001104659-26-068615
May 28, 2026DEFA14A0001104659-26-067154
May 15, 2026SCHEDULE 13G/A0002109159-26-000003
May 11, 20268-K0001104659-26-058666
May 11, 2026SCHEDULE 13G/A0002109159-26-000002
May 11, 202610-Q0001104659-26-058703